For decades, experts have struggled to pinpoint why the American health care system remains the most expensive in the world despite numerous legislative attempts to fix it. According to a Harvard professor who helped draft the Affordable Care Act, the answer lies not in current policy failures but in a deeper ideological shift that began forty years ago. This catalyst was neoliberalism, the free-market revolution championed by figures like Milton Friedman and Ronald Reagan during the late seventies and eighties. While critics often link this era to rising wealth inequality and environmental decay, its specific role in dismantling affordable medical care has remained largely overlooked by the general public.
The fallout of this ideology manifests primarily through aggressive corporate consolidation. By rewriting antitrust guidelines under the Reagan administration, the government essentially gave a green light to massive mergers provided they promised lower consumer costs—a promise that rarely materialized. Today, this has created a landscape dominated by monopolies where a handful of giant insurance firms and hospital systems control the vast majority of the market. In some sectors, such as dialysis providers, nearly all revenue flows into just two companies, leaving patients with virtually no competitive alternatives and skyrocketing prices.
Beyond simple mergers, the infiltration of private equity has further eroded the quality of patient care. Over a decade of explosive investment saw hundreds of billions of dollars pour into medical organizations, shifting the priority from clinical outcomes to shareholder returns. This trend toward privatization extends even to pillars like Medicare, where more than half of beneficiaries are now enrolled in privatized plans that benefit insurance giants rather than seniors. This systemic shift has caused public trust in medicine to plummet across party lines, falling from nearly eighty percent in 1975 to less than thirty percent today.
Correcting this trajectory requires more than incremental tweaks; it demands a fundamental reversal of these neoliberal trends. Proposals range from sweeping structural changes like Medicare for All to targeted interventions such as banning private equity from patient-facing care and empowering regulators to break up existing healthcare monopolies. Without regulating drug prices at launch and protecting patients via a renewed bill of rights, advocates argue that America will remain trapped in an inefficient and inequitable mess that prioritizes financial gamesmanship over human life.
